Pier L Zinzani Selected Research

Dacarbazine (DIC)

1/2018

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pier L Zinzani Research Topics

Disease

5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 01/2003
5	Neoplasms (Cancer) 01/2024 - 01/2012
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2023 - 08/2006
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2023 - 08/2011
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 11/2002
3	Lymphoma (Lymphomas) 10/2015 - 11/2002
2	Neutropenia 07/2023 - 01/2018
2	Hairy Cell Leukemia 01/2021 - 10/2015
1	Atrial Fibrillation 07/2023
1	Hemorrhage 07/2023
1	Hypertension (High Blood Pressure) 07/2023
1	Infections 07/2023
1	Lymphocytosis 07/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022
1	Disease Progression 01/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2018
1	Febrile Neutropenia 01/2018
1	Exanthema (Rash) 10/2015
1	Arthralgia (Joint Pain) 10/2015
1	Arthritis (Polyarthritis) 10/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2015
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2012
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2011

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 02/2023 - 11/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 11/2002
3	Vincristine (Oncovin)FDA LinkGeneric 10/2015 - 11/2002
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 11/2002
2	Agammaglobulinaemia Tyrosine KinaseIBA 07/2023 - 01/2022
2	VemurafenibIBA 01/2021 - 10/2015
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018 - 01/2003
2	Lenalidomide (CC 5013)FDA Link 11/2011 - 08/2011
2	Prednisone (Sone)FDA LinkGeneric 01/2003 - 11/2002
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024
1	axicabtagene ciloleucelIBA 01/2024
1	venetoclaxIBA 07/2023
1	pirtobrutinibIBA 07/2023
1	CT-P10IBA 02/2023
1	Biosimilar PharmaceuticalsIBA 02/2023
1	Circulating Tumor DNAIBA 11/2022
1	Complement System Proteins (Complement)IBA 11/2022
1	ibrutinibIBA 01/2022
1	Bendamustine Hydrochloride FDA Link 01/2022
1	loncastuximab tesirineIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	Brentuximab VedotinIBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2018
1	purineIBA 10/2015
1	Prednisolone (Predate)FDA LinkGeneric 10/2015
1	Histone Deacetylase InhibitorsIBA 10/2015
1	fludarabineIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	epratuzumabIBA 08/2006
1	Methotrexate (Mexate)FDA LinkGeneric 01/2003
1	Transcription Factors (Transcription Factor)IBA 01/2003
1	Etoposide (VP 16)FDA LinkGeneric 11/2002
1	CD20 AntigensIBA 11/2002
1	Monoclonal AntibodiesIBA 11/2002

Therapy/Procedure

8	Therapeutics 07/2023 - 11/2002
5	Drug Therapy (Chemotherapy) 01/2024 - 11/2002
1	Transplantation 01/2024
1	Duration of Therapy 07/2023
1	Organ Transplantation 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Precision Medicine 11/2022
1	Radioimmunotherapy 01/2018
1	Aftercare (After-Treatment) 10/2015
1	Drug Tapering 10/2015
1	Immunotherapy 08/2006
1	Radiotherapy 01/2003
1	Salvage Therapy 11/2002
1	Stem Cell Transplantation 11/2002